Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krishna Institute of Medical Sciences has informed that a meeting of the Board of Directors of the company is scheduled to be held on Thursday, May 18, 2023, to consider and approve the Audited (Standalone & Consolidated) Financial results of the company for the quarter and financial year ended March 31, 2023. Further, in accordance with the Company’s Code of Conduct for the Prevention of Insider Trading, the Company has intimated its ‘designated persons’ regarding the closure of the Trading Window for trading in the Company’s equity shares from Saturday, April 01 2023 till the expiry of 48 hours from the date the said financial results are made public.
The above information is a part of company’s filings submitted to BSE.
